MandADeals
Search the site:
Dechra Pharm
Market Type Industry Raised Date
AIM Acquisition Pharmaceuticals & Biotech £61.7m Dec 2007
 

CONTACTS

CEO: Keith Page +44 (0) 1782 771100
 

ADVISERS

Citigate Dewe Rogerson
Patrick Donovan
020-7638 9571
3 London Wall
London
EC2M 5SY
Rothschild Bioscience Unit

020-7634 2883
Rothschild Asset Management Ltd, Fiver Arrows Housde, St Swithin's Lane
London
EC4N 8NR

COMMENT

Dechra Pharm plc, a veterinary pharmaceutical products and services supplier, is set to expand with the acquisition of Denmark-based VetXX for £61.7 million cash.

CEO: Ian Page: +44 (0) 1782 771100

Related Articles


People who read this article also read ...